Loading...
*  Immunization during pregnancy
BCG vaccine is used against tuberculosis and is contraindicated in pregnancy. Inactivated bacterial vaccine is used during ... Hib can cause bacterial meningitis and pneumonia. There was not enough research found in the review to show whether giving the ... The tetanus vaccine (tetanus toxoid) has shown to be successful in preventing babies from developing tetanus and deaths from ... Immunization during pregnancy, that is the administration of a vaccine to a pregnant woman, is not a routine event as it is ...
*  H5N1 clinical trials
The universal vaccine is made through bacterial fermentation technology, which would greatly speed up the rate of production ... This is the first VRC candidate vaccine manufactured at the VRC Vaccine Pilot Plant. The candidate vaccine went from the ... The DNA vaccine used in this study is similar to other investigational vaccines evaluated by the VRC that hold promise for ... A typical dose of seasonal flu vaccine is 15 mcg. "This is the first time such a low dose of H5N1 vaccine has been able to ...
*  Gastroenteritis
For example, vaccines against Shigella and enterotoxigenic Escherichia coli (ETEC), two of the leading bacterial causes of ... If the stool is bloody, the cause is less likely to be viral and more likely to be bacterial. Some bacterial infections may be ... Two commercial rotavirus vaccines exist and several more are in development. In Africa and Asia these vaccines reduced severe ... The first dose of vaccine should be given to infants between 6 and 15 weeks of age. The oral cholera vaccine has been found to ...
*  Attack rate
... in marshalling resources for delivery of medical care as well as production of vaccines and/or anti-viral and anti-bacterial ... Compartmental models in epidemiology Herd immunity Risk assessment in public health Vaccine-naive Anthony N. Glaser. High-Yield ...
*  Vaccine controversies
Vaccine burden: Miller E, Andrews N, Waight P, Taylor B (2003). "Bacterial infections, immune overload, and MMR vaccine". Arch ... when the routine vaccine schedule could contain more than 3,000 antigens (in a single shot of DTP vaccine). The vaccine ... Vaccine. 24 (20): 4321-7. doi:10.1016/j.vaccine.2006.03.003. PMID 16581162. Hurst L (2009-10-30). "Vaccine phobia runs deep". ... Vaccine. 32 (29): 3623-9. doi:10.1016/j.vaccine.2014.04.085. PMID 24814559. Baker JP (2008). "Mercury, Vaccines, and Autism: ...
*  Thiomersal controversy
... is an organomercury compound used as a preservative in vaccines since the 1930s to prevent bacterial and fungal contamination. ... including the Hib vaccine, DTaP vaccine and hepatitis B vaccine, could have contained thiomersal. Third, the number of ... but vaccine advocates doubt their utility given the lack of evidence for danger with thiomersal in vaccines. Vaccine advocates ... Second, the vaccine schedule for infants expanded in the 1990s to include more vaccines, some of which, ...
*  Anthrax Vaccine Adsorbed
Other uncharacterized bacterial byproducts are also present. Whether or not the EF and LF contribute to the vaccine's efficacy ... For anthrax vaccines generally, see Anthrax vaccines. Anthrax Vaccine Adsorbed (AVA) - also called MDPH-PA or MDPH-AVA; trade ... U.S. anthrax vaccine package insert Gulf War Syndrome Fact or Fiction. Anthrax.osd.mil - 'AVIP: Anthrax Vaccine Immunization ... to supply up to 75 million doses of a recombinant anthrax vaccine, for $877 million. To be acceptable to HHS, this vaccine was ...
*  Pneumococcal Awareness Council of Experts
As the three leading causes of bacterial meningitis in childhood are vaccine preventable, the regular use of conjugate vaccines ... Sequelae Due to Bacterial Meningitis among African Children: A Systematic Literature Review, and Bacterial Infections in ... is a project of the Sabin Vaccine Institute and is composed of global experts in infectious diseases and vaccines. Established ... "Bacterial Infections in Persons with Sickle Cell Disease: A Review of Data from Africa with a Focus on Pneumococcal Disease" " ...
*  Protein subunit
... bacterial vector) to make a recombinant virus or bacteria to serve as the important component of a recombinant vaccine (called ... Vi capsular polysaccharide vaccine (ViCPS) is another subunit vaccine (contains the signature polysaccharide linked to the Vi ... A subunit vaccine presents an antigen to the immune system without introducing viral particles, whole or otherwise. One method ... This is the type of vaccine currently in use for hepatitis B, and it is experimentally popular, being used to try to develop ...
*  Meningococcal vaccine
FDA approves new combination vaccine that protects children against two bacterial diseases Archived 2012-06-16 at the Wayback ... A vaccine called MenAfriVac has been developed through a program called the Meningitis Vaccine Project and has the potential to ... "First ever MenB vaccine available for use" Archived 2014-10-25 at the Wayback Machine., Oxford Vaccine Group openminds blog ... Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis. Different versions are ...
*  Attenuated vaccine
... chicken pox vaccine, smallpox vaccine, oral polio vaccine (Sabin), rotavirus vaccine, and yellow fever vaccine. Bacterial: BCG ... vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine, Live attenuated influenza vaccine (the seasonal flu ... An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). ... These vaccines contrast to those produced by "killing" the virus (inactivated vaccine). Examples of "live" (example attenuated ...
*  Akiko Iwasaki
Overall, the goal is to design effective vaccines or microbiocides for the prevention of transmission of viral and bacterial ... coded for by the vaccines because the DNA vaccines work best when injected into the muscle. Iwasaki's research continues to ...
*  World Pneumonia Day
There are effective vaccines against the two most common bacterial causes of deadly pneumonia, Haemophilus influenzae type B ... Malaria & Pneumonia, the Global Health Council, the GAVI Alliance, and the Sabin Vaccine Institute joined together in a call to ...
*  Conjugate vaccine
"Polysaccharide Vaccines for Prevention of Encapsulated Bacterial Infections: Part 1". Infect Med. 19: 127-133. Vaccines, ... B cell Haemophilus influenzae type b (Hib) Hib vaccine Immunogenicity Meningococcal vaccine Pneumococcal vaccines Rappuoli, ... "Use of carrier protein for development of protein/polysaccharide conjugate vaccines and protein/protein conjugate vaccines". ... A conjugate vaccine is created by covalently attaching a poor antigen to a strong antigen thereby eliciting a stronger ...
*  Koch-Pasteur rivalry
... whereas Pasteur's acceptance of variation suggested attenuating bacterial virulence in the laboratory to develop vaccines. ... Amid anthrax vaccine's success, Pasteur introduced rabies vaccine (1885), the first human vaccine since Jenner's smallpox ... BCG vaccine was not used in the public health of America, which virtually eliminated tuberculosis without it. BCG vaccine's ... Rivalry over a vaccine]. Histoire des Sciences M├ędicales (in French). 44 (1): 55-64. PMID 20527335. Koch R & Carter KC, Essays ...
*  Meningitis
Segal S, Pollard AJ (2004). "Vaccines against bacterial meningitis" (PDF). British Medical Bulletin. 72 (1): 65-81. doi:10.1093 ... A quadrivalent vaccine now exists, which combines four vaccines with the exception of B; immunization with this ACW135Y vaccine ... Meningococcus vaccines exist against groups A, B, C, W135 and Y. In countries where the vaccine for meningococcus group C was ... With appropriate treatment the risk of death in bacterial meningitis is less than 15%. Outbreaks of bacterial meningitis occur ...
*  Lloyd Mayer
1 R21 AI083381-01 Oral Vaccine Platform for Class A Bacterial Agents, NIH, 1 R01 AI084952 Generation and Characterization of ... "Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines". Inflamm. Bowel Dis. 18 (2): 261-8 ...
*  Otitis media
Influenza vaccine is recommended annually for all children. PCV does not appear to decrease the risk of otitis media when given ... This can be associated with a viral URI or bacterial infection such as otitis media. An effusion can cause conductive hearing ... Pneumococcal conjugate vaccines (PCV) in early infancy, decreases the risk of acute otitis media in healthy infants. PCV is ... Benninger, Michael S. (2008-03-01). "Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following ...
*  Pneumococcal conjugate vaccine
The bacterial capsule sugars, a characteristic of these pathogens, are linked to CRM197, a nontoxic recombinant variant of ... Pneumococcal conjugate vaccine (PCV) is a pneumococcal vaccine and a conjugate vaccine used to protect infants, young children ... Barocchi MA, Censini S, Rappuoli R (2007). "Vaccines in the era of genomics: the pneumococcal challenge". Vaccine. 25 (16): ... Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center (2013). "VIMS Report: Global vaccine ...
*  Fiona Brinkman
This method aids the prediction of cell surface and secreted proteins in a bacterial cell that may be suitable drug targets, ... vaccine components or diagnostics. She has also developed bioinformatics methods that aid the more accurate identification of ... Gardy, J.L., and F.S.L. Brinkman (2006). Methods for predicting bacterial protein subcellular localization. Nature Reviews ... Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. ...
*  Tawny-bellied cotton rat
It is affected by many of the same viral and bacterial infections that humans are susceptible to, which helps create vaccines ...
*  Ursula Wiedermann
Vaccine. 29 (10): 1981-90. doi:10.1016/j.vaccine.2010.12.101. PMID 21216308. Hoflehner E; Hufnagl K; Schabussova I; Jasinska J ... "Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization". ... This vaccine is currently being taken into mid-stage clinical development in gastric cancer by the biotech company Imugene, ... Wiedermann's work in the field of B cell peptide vaccines led to the creation of HER-Vaxx, an immunotherapy for the treatment ...
*  Avian pneumovirus
There is no specific treatment but antibiotics should be given to prevent secondary bacterial infections. A vaccine is ...
*  Antigenic escape
In order to fix this problem, vaccines must be able to cover the wide variety of strains within a bacterial population. In ... While vaccines are created to strengthen the immune response to pathogens, in many cases these vaccines are not able to cover ... The problem of antigenic escape has greatly deterred the process of creating new vaccines. Because vaccines generally cover a ... Recent research on many vaccines, including the malaria vaccine, has focused on how to anticipate this diversity and create ...
*  Cancer vaccine
These vaccines are not further discussed in this article. Other cancers are to some extent caused by bacterial infections (e.g ... A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat ... Traditional vaccines against those viruses, such as HPV vaccine and hepatitis B vaccine, prevent those types of cancer. ... In one approach, vaccines contain whole tumor cells, though these vaccines have been less effective in eliciting immune ...
*  Marc Baldus
He has used the technology amongst others to study the behavior of bacterial proteins, protein aggregation in Alzheimer's and ... Revealing Multiple Conformations in Lipid-Anchored Peptide Vaccines". Angewandte Chemie International Edition. 52 (41): 10905. ...
*  Vaccine and Infectious Disease Organization
VIDO-InterVac was a member of three National Networks of Centres of Excellence: the Canadian Bacterial Diseases Network, the ... The Vaccine and Infectious Disease Organization-International Vaccine Centre is a research organization of the University of ... In March 2003, VIDO's name was changed to the Vaccine and Infectious Disease Organization. In October 2003 a 50,000 sq ft ( ... Ecolan RC (cattle) - Prevention of bacterial and viral calf scours Hevlan TC (poultry) - Prevention of enteritis in turkeys ...